On Sept. 13, 2016, Arbutus Biopharma announced that Dr. Michael J. Sofia, Arbutus’ Chief Scientific Officer, had been awarded the 2016 Lasker-DeBakey Clinical Medical Research Award for the development of a revolutionary treatment of hepatitis C virus (HCV).

Dr. Sofia leads a world class team of scientists at Arbutus that is focused on developing innovative therapies to improve cure rates in HBV.